New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - oxymetazoline hydrochloride 0.25 mg/ml - nasal drops - 250 mcg/ml - active: oxymetazoline hydrochloride 0.25 mg/ml excipient: benzalkonium chloride cherry flavour 051849 c glycine propylene glycol purified water sodium hydroxide sorbitol

New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - oxymetazoline hydrochloride 0.05% - nasal drops - 0.05 % - active: oxymetazoline hydrochloride 0.05% excipient: benzalkonium chloride glycine hydrochloric acid phenylmercuric acetate purified water sodium hydroxide sorbitol

New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - oxymetazoline hydrochloride 0.025% - nasal drops - 0.025 % - active: oxymetazoline hydrochloride 0.025% excipient: benzalkonium chloride glycine hydrochloric acid phenylmercuric acetate purified water sodium hydroxide sorbitol

New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - oxymetazoline hydrochloride 0.025% - nasal drops - 0.025 % - active: oxymetazoline hydrochloride 0.025%

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - oxymetazoline hydrochloride, quantity: 0.5 mg/ml - spray, nasal - excipient ingredients: dibasic sodium phosphate; povidone; cineole; menthol; propylene glycol; benzyl alcohol; benzalkonium chloride; camphor; monobasic sodium phosphate monohydrate; macrogol 1450; dispersible cellulose; purified water; disodium edetate - symptomatic relief of nasal and nasopharyngeal congestion associated with the common cold and flu, hayfever and sinusitis, and to facilitate visual intranasal examination. by decreasing congestion around the eustachian tube ostia, drixine nasal may be useful in the adjunctive treatment of congestion associated with middle ear conditions.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - oxymetazoline hydrochloride, quantity: 0.5 mg/ml - spray, nasal - excipient ingredients: povidone; purified water; glycerol; macrogol 1450; dispersible cellulose; dibasic sodium phosphate; benzalkonium chloride; monobasic sodium phosphate monohydrate; benzyl alcohol; disodium edetate; flavour - symptomatic relief of nasal and nasopharyngeal congestion associated with the common cold and flu, hayfever and sinusitis, and to facilitate visual intranasal examination. by decreasing congestion around the eustachian tube ostia, drixine nasal may be useful in the adjunctive treatment of congestion associated with middle ear conditions.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - oxymetazoline hydrochloride, quantity: 0.5 mg/ml - spray, nasal - excipient ingredients: disodium edetate; dibasic sodium phosphate; benzalkonium chloride; povidone; dispersible cellulose; monobasic sodium phosphate monohydrate; purified water; macrogol 1450; benzyl alcohol; flavour - symptomatic relief of nasal and nasopharyngeal congestion associated with the common cold, flu, hayfever and sinusitis, and to facilitate visual intranasal examination. by decreasing congestion around the eustachian tube ostia, drixine nasal may be useful in the adjunctive treatment of congestion associated with middle ear conditions.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - oxymetazoline hydrochloride, quantity: 0.5 mg/ml - spray, nasal - excipient ingredients: sodium hydroxide; hydrochloric acid; propylene glycol; monobasic sodium phosphate monohydrate; disodium edetate; purified water; benzalkonium chloride - indicated for symptomatic relief of nasal and nasopharyngeal congestion associated with the common cold, hayfever and sinusitis, and to facilitate visual intranasal examination. by decreasing congestion around the eustachian tube ostia, drixine nasal may be useful in the adjunctive treatment of congestion associated with middle ear conditions.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - oxymetazoline hydrochloride 0.5 mg/ml - nasal spray solution - 500 mcg/ml - active: oxymetazoline hydrochloride 0.5 mg/ml excipient: benzalkonium chloride hydrochloric acid monobasic sodium phosphate monohydrate propylene glycol purified water sodium edetate sodium hydroxide

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - oxymetazoline hydrochloride 0.5 mg/ml - nasal spray solution - 500 mcg/ml - active: oxymetazoline hydrochloride 0.5 mg/ml excipient: benzalkonium chloride benzyl alcohol camphor cineole dibasic sodium phosphate disodium edetate dihydrate dispersible cellulose menthol monobasic sodium phosphate monohydrate polyethylene glycol 1450 povidone propylene glycol purified water